Publication | Closed Access
The CD4+/CD8+ ratio as a prognostic factor in patients with metastatic melanoma receiving chemoimmunotherapy.
33
Citations
21
References
1996
Year
The monitoring of early changes in the CD4+/CD8+ ratio can provide valuable information that predicts the prognosis of metastatic melanoma patients receiving chemoimmunotherapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1